波蘭主流電視播出問題豬流感疫苗成份

2009年12月30日波蘭主流電視播出被污染的有毒豬流感疫苗成份：

(英文字幕)
Truth about vaccines - Polish TV TVN (program "Attention") 30.12.2009
疫苗真相 - 波蘭電視TVN（節目“注意”）09年12月30日


了解H1N1疫苗小疑團
10/26/2009 at 10:00 pmNo Comment
每年大約時這間，都會聽到有關流感的報導，而今年因新型H1N1病毒散播全球，有關疫情的報告更早在春季已不斷發送。為了進一步預防疫情擴散，各國政府都推出大型的H1N1疫苗注射計劃。然而，民間對今年的新H1N1疫苗的安全性卻存着許多懷疑。其中的疑團包括：
1. 先有未驗証的研究報告指出，季節性流感疫苗(S.F.V)有令人更易染上H1N1之虞，以致卑詩省及其他幾個省份要臨時改用分部制，推出季節性流感疫苗(S.F.V)。
.
2. 另外具爭議性關注，是今年H1N1疫苗裏的佐劑(Adjuvant)含有「角鯊烯(Squalene)」。佐劑的作用是加强身體對病毒的反應，以致小量的病毒也能使身體產生足夠的抗體。以往也有其他類型的佐劑用於其它疫苗中。
但這次H1N1疫苗含有「角鯊烯」的佐劑，卻是第一次在加拿大使用，其爭議性主要在於：
a. 1990 - 91年，海灣戰爭(Gulf War)中部份軍人的炭疽疫苗(anthrax vaccine)及這些軍人以後患上的長期肌肉神經或免疫系統症狀(G.W.S)的關係。有多個獨立研究報告指出兩者有正面的關係，但也有藥廠及政府的大型研究否定它們的關係。
在民間(尤其在美國)有許多組織要求禁止含有角鯊烯的疫苗，美國政府亦一直未通過使用這些疫苗，今次亦不例外。

b. 2006年GlaxoSmithKline製的H5N1疫苗含有角鯊烯，通過批准在歐盟及東南亞地區(包括香港)都有使用。

c. 第二批GSK所製，即今年的H1N1疫苗仍含有包含角鯊烯的佐劑。這是加拿大政府及歐盟所選定應付H1N1的疫苗之一。在加拿大，除了孕婦和3歲以下的小孩，其他人都會選用這種疫苗。GSK在本月16日發出新聞稿，指疫苗已証實為安全，加拿大當局亦堅稱有足夠証明顯示疫苗的安全性。

看著這許多的報導及討論後，市民真有不知何去何從之感。這邊廂H1N1的威脅是貼身又緊迫的；那邊廂疫苗又好像存有潛在的危機。無論如何，能清楚地知道相對的風險而作出選擇都是幸福的。而除了將注意力集中於是否注射疫苗外，我們也當在其他方面積極地參予預防流感的行列，包括：
1. 避免自己受感染 (切記勤洗手，保護眼鼻口，避免跟患者接觸，保持身心靈建康)
2. 避免成為傳播細菌者 (若有流感徵狀就留在家中，不要隨地吐痰)
3. 有計劃地作出應變 (密切留意疫情資訊)

作者 雷詠雯 (資深註冊護士)
http://www.kpost.ca/?p=3187

諾華在波蘭以人測試豬流感疫苗 未經批准
NOVARTIS TESTED SWINE FLU VACCINE ON PEOPLE IN POLAND WITHOUT AUTHORISATION
Thursday, 07 January 2010 11:40
The Swiss pharmaceutical company Novartis appears to have tested the swine flu jab with squalene on people in Poland without authorisation and without informing the participating doctors, hospitals and clinics about the content of the vaccine material, according to a report on Polskaweb.
http://polskaweb.eu/illegale-ahn1n1-impfstoff-tests-in-polen-7367356752562.html
Novartis tested its swine flu vaccine "Focetria" on Polish people without informing them or the doctors who administered it about its name or origin, investigative journalists from Poland's TVN found out.
The Polish health ministry has issued a statement saying that no authorisation for clinical trials involving the swine flu vaccine was given to Novartis, although trials for bird flu vaccines were authorised last September.
"Neither the Health Ministry nor the Registration Office For Drugs and Medicines have given any pharmaceutical company permission for clinical studies using a vaccine against the "swine flu" H1N! in Poland," the health ministry said in a press release.
Novartis has refused to confirm whether they received authorisation or not. The Novartis subsidiary in Warsaw has directed inquiries to the company headquarters in Switzerland.
The EMEA, the European drug regulator, website indicates Novartis has tested its Focetria drug.
"We have tested the vaccine until now on 661 "health adults of all age groups. A similar study has also been carried out with 720 health children and young people from 6 months to 17 years of age," material says.
Novartis has refused to comment on where these tests were carried out, but 1381 Polish children and adults could have been involved in these tests in Poland.
However, Polskaweb points out that Novartis may never conducted tests on the swine flu vaccine at all and have tested something else in Poland.
Warschau - Polnische Journalisten sind offenbar einem weiterem Piratenstück der Pharma- Industrie auf der Spur. Wie der Nachrichtensender TVN berichtet, soll der Sch....

http://www.theflucase.com/index.php?option=com_content&view=article&id=2491%3Anovartis-tested-swine-flu-vaccine-on-people-in-poland-without-authorisation&catid=41%3Ahighlighted-news&Itemid=105&lang=en

豬流感疫苗訂單取消(愛爾蘭370萬劑)
Order for swine flu vaccines cancelled
Eithne Donnellan
An order placed by the State for some 3.7 million doses of swine flu vaccine from the Baxter pharmaceutical company has been cancelled, the Health Service Executive has confirmed, writes .
It said the vaccines were no longer required now that experts agreed most people would only require one dose. It was originally envisaged two jabs would be required.
A spokeswoman said this would result in a saving of €25 million to €35 million.
http://www.irishtimes.com/newspaper/ireland/2010/0106/1224261733260.html